Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Flixotide to reduce perioperative respiratory adverse events in children undergoing adenotonsillectomy
ACTRN12619000243112Phase 4Terminated
- Sponsor
- Kids Research Institute Australia
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate in adverse respiratory event (ARE), sponsored by Kids Research Institute Australia. Primary endpoint: Perioperative respiratory adverse events. Started Sep 2019; status: terminated.
02
Drugs
fluticasone propionate
03
Conditions
adverse respiratory event (ARE)
Beyond the preview
Go deeper on ACTRN12619000243112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000243112.